Clarivate Plc · NYSE:CLVT

Clarivate — William Blair's 42nd Annual Growth Stock Conference (June 2022)

23 slides from Clarivate's conference presentation, Jun 9, 2022

  1. Slide 1: William Blair Conference Investor Presentation

    William Blair Conference Investor Presentation June 9, 2022

  2. Slide 2: Safe Harbor Statement and Non-GAAP Financial Measures

    Safe Harbor Statement and Non-GAAP Financial Measures Forward-Looking Statements This communication contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management’s current views concerning future business, events,

  3. Slide 3: Jerre Stead, Executive Chair & Chief Executive Officer

    Jerre Stead Executive Chair & Chief Executive Officer

  4. Slide 4: The Clarivate Story

    The Clarivate Story 2022 – 2023 • Launched ‘One Clarivate’ • Targeting organic growth rate of 2021 ~6.5% (+200 bps) • Outlined ‘One Clarivate’ • Adjusted EBITDA Margin • Launched inside sales expansion of ~300-500 bps • Continued inorganic growth • Poised to achieve mid-term 2019 – 2020 targets and

  5. Slide 5: Business model provides clear path to long-term profitable growth

    Business model provides clear path to long-term profitable growth Recurring subscription revenue with high Recurring revenue retention and revenue visibility + profitable ‘Build once, sell many times’ creates incremental growth significant operating leverage Low capital requirements allow high cash

  6. Slide 6: Implemented One Clarivate

    Implemented One Clarivate Over $100B of Addressable Opportunity Our strategy to capture growth opportunity while increasing Academia & Government Life Sciences & Healthcare customer delight Academia; Applied R&D; Pharma; Healthcare; Publishing; Gov’t; Non-Profit ~$1.36B Medical Devices ~$590M With t

  7. Slide 7: Committed to Sustainability

    Committed to Sustainability Goal: carbon neutral by 2024 Aiming to be listed on DJ Sustainability Index and FTSE 4 GOOD Index based on 2023 performance 7

  8. Slide 8: Jonathan Collins, Executive Vice President & Chief Financial Officer

    Jonathan Collins Executive Vice President & Chief Financial Officer

  9. Slide 9: FY 2022 Quarterly Progression

    FY 2022 Quarterly Progression  Expect normal revenue Revenue Phasing seasonality with elevated $ millions levels in Q2 and Q4 due to $900 transactional sales  Anticipate organic growth $800 rate to progressively improve ~$690 $700 $662 through the year  Q2 organic growth expected $600 at ~5.5% to

  10. Slide 10: FY 2022 Outlook

    FY 2022 Outlook  Affirming full year guidance Full Year Guidance Ranges ranges, which are unchanged  Expect revenue growth of ~$2.84B nearly $1B bolstered by full $2.88B year of ProQuest business Revenue $2.8B and ~6.5% organic constant currency growth ~$1.19B  Anticipate Adj. EBITDA Adj. EBITDA

  11. Slide 11: Key Financial Metrics Trends

    Key Financial Metrics Trends  Revenue set to triple in 5 years Revenue Adjusted EBITDA bolstered by M&A and $ billions $ millions ~$2.8 ~$3.0 improving organic growth ~$1,190 ~6.5% $800  Adj. EBITDA expected to $1.9 increase by ~50% in 2022 and $478 $1.2 4.5% ~ 42% margins are poised to expand $0.

  12. Slide 12: Investment Highlights

    Investment Highlights Leading Brands Accomplished Global Leadership Customer Team Base Substantial $100B Free Cash Addressable Flow Market Generation ~80% Significant Subscription / Operating Re-occurring Leverage Revenue 90%+ Subscriber Retention Rates 12

  13. Slide 13: Appendix

    (S Clarivate” APPENDIX

  14. Slide 14: Presentation of Certain Non-GAAP Financial Measures

    Presentation of Certain Non-GAAP Financial Measures This presentation contains financial measures which have not been calculated in accordance with generally accepted accounting principles in the United States of America (“US GAAP“), including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net In

  15. Slide 15: Presentation of Certain Non-GAAP Financial Measures

    Presentation of Certain Non-GAAP Financial Measures Adjusted EBITDA The use of Adjusted EBITDA instead of US GAAP has limitations as an analytical tool, and you should not consider Adjusted EBITDA in isolation, or as a substitute for analysis of the Company’s results of operations and operating cash

  16. Slide 16: Presentation of Certain Non-GAAP Financial Measures

    Presentation of Certain Non-GAAP Financial Measures Adjusted Net Income and Adjusted Diluted EPS We use Adjusted Net Income and Adjusted Diluted Earnings Per Share ("Adjusted Diluted EPS") in our analysis of the financial performance of the Company. We believe Adjusted Net Income and Adjusted Dilute

  17. Slide 17: Presentation of Certain Non-GAAP Financial Measures

    Presentation of Certain Non-GAAP Financial Measures Free Cash Flow and Adjusted Free Cash Flow We use free cash flow and adjusted free cash flow in our operational and financial decision-making and believe free cash flow and adjusted free cash flow is useful to investors because similar measures are

  18. Slide 18: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Descriptions Net Loss to Adjusted EBITDA Adjusted EBITDA adjustments 1. Reflects the deferred revenues adjustment made as a result of purchase accounting prior to the adoption of FASB ASU No. 2021-08, Accounting for Contract Assets and Contract Liabiliti

  19. Slide 19: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Net Loss and Net Loss Per Share to Adjusted Net Income and Adjusted Diluted EPS Year Ended December 31, Year Ended December 31, Descriptions 2021 2020 Adjusted Net Income and Adjusted Diluted EPS adjustments (in millions, except per share amounts); (unau

  20. Slide 20: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Descriptions Net Cash Provided By (Used In) Operating Activities to Free Cash Flow and Adjusted Free Cash Flow Free Cash Flow and Adjusted Free Cash Flow Adjustments 1. Reflects cash payments for costs primarily related to restructuring and Year Ended De

  21. Slide 21: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures The following table presents our calculation of Revenues, net, Adjusted EBITDA and Adjusted EBITDA Margin for the Outlook for 2022 and reconciles this measure to Revenues for the same period: Revenues, Net Variance Increase/(Decrease) Percentage of Facto

  22. Slide 22: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures The following table presents our calculation of Adjusted Diluted EPS for the FY2022 Outlook and reconciles this measure to our Net loss for the same period: Net Loss Per Fully Diluted Weighted Shares Outstanding to Adjusted Diluted EPS Year Ending Decemb

  23. Slide 23: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures The following table presents our calculation of Free Cash Flow and Adjusted Free Cash Flow for the FY2022 Outlook and reconciles this measure to our Net cash provided by operating activities for the same period: Net Cash Provided by Operating Activities

Clarivate — William Blair's 42nd Annual Growth Stock Conference (June 2022) on 6ix